• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异常甲基化的 MEG3 可作为宫颈癌潜在的基于血浆的生物标志物。

Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer.

机构信息

Department of Obstetrics and Gynecology, The Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Shenzhen, 518020, People's Republic of China.

Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, People's Republic of China.

出版信息

Sci Rep. 2017 Jul 24;7(1):6271. doi: 10.1038/s41598-017-06502-7.

DOI:10.1038/s41598-017-06502-7
PMID:28740189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5524906/
Abstract

Methylation alterations of specific genes have recently been identified as diagnostic biomarkers for human cancers. Although MEG3 has been proved to be a tumor suppressor in cervical cancer according to our previous study, the diagnostic value of MEG3 methylation in plasma is still unknown. Therefore, the aim of this study is to identify a novel epigenetic biomarker for cervical cancer. In the current study, the level of MEG3 methylation was evaluated using methylation-specific polymerase chain reaction. The results showed that the level of MEG3 methylation was significantly higher in cervical cancer tissues and patients' plasmas than those in adjacent normal tissues and plasmas of healthy participants respectively. Moreover, the accuracy was good enough for MEG3 methylation in plasma to discriminate CIN III patients from healthy participants. In addition, MEG3 methylation in plasma also has high discriminating power to predict HR-HPV infection and lymph node metastasis. Furthermore, hypermethylation of MEG3 in plasma was associated with worse recurrence-free and overall survival in cervical cancer patients. In conclusions, MEG3 methylation in plasma can serve as a diagnostic and prognostic biomarker for cervical cancer, providing useful information for clinical management.

摘要

近年来,特定基因的甲基化改变已被确定为人类癌症的诊断生物标志物。虽然根据我们之前的研究,MEG3 已被证明是宫颈癌的肿瘤抑制因子,但 MEG3 甲基化在血浆中的诊断价值尚不清楚。因此,本研究旨在确定一种新的宫颈癌表观遗传生物标志物。在本研究中,采用甲基化特异性聚合酶链反应评估 MEG3 甲基化水平。结果表明,与相邻正常组织和健康参与者的血浆相比,宫颈癌组织和患者血浆中的 MEG3 甲基化水平显著升高。此外,MEG3 血浆甲基化在区分 CIN III 患者和健康参与者方面具有足够好的准确性。此外,血浆中 MEG3 的甲基化也具有很高的区分能力,可预测 HR-HPV 感染和淋巴结转移。此外,血浆中 MEG3 的高甲基化与宫颈癌患者无复发生存和总生存不良相关。总之,血浆中的 MEG3 甲基化可作为宫颈癌的诊断和预后生物标志物,为临床管理提供有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/b4bf62bfa363/41598_2017_6502_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/18056bbde4f7/41598_2017_6502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/b6f649a09700/41598_2017_6502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/8fa2368e4239/41598_2017_6502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/f6a90010af81/41598_2017_6502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/b4bf62bfa363/41598_2017_6502_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/18056bbde4f7/41598_2017_6502_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/b6f649a09700/41598_2017_6502_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/8fa2368e4239/41598_2017_6502_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/f6a90010af81/41598_2017_6502_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a454/5524906/b4bf62bfa363/41598_2017_6502_Fig5_HTML.jpg

相似文献

1
Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer.异常甲基化的 MEG3 可作为宫颈癌潜在的基于血浆的生物标志物。
Sci Rep. 2017 Jul 24;7(1):6271. doi: 10.1038/s41598-017-06502-7.
2
Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.长链非编码RNA MEG3的下调与宫颈癌的不良预后及启动子高甲基化相关。
J Exp Clin Cancer Res. 2017 Jan 5;36(1):5. doi: 10.1186/s13046-016-0472-2.
3
Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.异常的启动子甲基化可作为宫颈上皮内瘤变III级患者复发疾病的标志物。
Tumori. 2007 Nov-Dec;93(6):572-9. doi: 10.1177/030089160709300610.
4
Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.长链非编码RNA MEG3在宫颈癌中表达下调,并通过调控miR-21影响细胞增殖和凋亡。
Cancer Biol Ther. 2016;17(1):104-13. doi: 10.1080/15384047.2015.1108496.
5
High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.高迁移率族蛋白B1在宫颈癌中过表达,并在体外促进细胞侵袭和迁移。
Oncol Rep. 2017 Feb;37(2):831-840. doi: 10.3892/or.2016.5317. Epub 2016 Dec 14.
6
Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.异常甲基化介导的lncRNA MEG3沉默在食管癌中作为竞争性内源RNA发挥作用。
Mol Cancer Res. 2017 Jul;15(7):800-810. doi: 10.1158/1541-7786.MCR-16-0385. Epub 2017 May 24.
7
Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.使用甲基化DNA免疫沉淀测序(MethylCap-seq)进行全基因组甲基化组分析,发现了4个对宫颈腺癌和鳞癌均具有高敏感性的高甲基化标志物。
Oncotarget. 2016 Dec 6;7(49):80735-80750. doi: 10.18632/oncotarget.12598.
8
RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.RASSF1A启动子甲基化与宫颈癌的发生、发展及转移相关:一项采用序贯试验分析的荟萃分析
Arch Gynecol Obstet. 2018 Feb;297(2):467-477. doi: 10.1007/s00404-017-4639-7. Epub 2017 Dec 29.
9
Identification of novel DNA methylation markers in cervical cancer.宫颈癌中新的DNA甲基化标志物的鉴定。
Int J Cancer. 2008 Jul 1;123(1):161-7. doi: 10.1002/ijc.23519.
10
Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.PAX1 基因甲基化状态的定量分析用于宫颈癌的检测。
Int J Gynecol Cancer. 2010 May;20(4):513-9. doi: 10.1111/IGC.0b013e3181c7fe6e.

引用本文的文献

1
Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders.外泌体生物标志物:恶性和非恶性疾病诊断及预后应用的全面概述
Biomolecules. 2025 Apr 15;15(4):587. doi: 10.3390/biom15040587.
2
Bioinformatics analysis proposes a possible role for long noncoding RNA MIR17HG in retinoblastoma.生物信息学分析提出长非编码 RNA MIR17HG 在视网膜母细胞瘤中可能发挥作用。
Cancer Rep (Hoboken). 2024 Feb;7(2):e1933. doi: 10.1002/cnr2.1933. Epub 2024 Feb 6.
3
Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker.

本文引用的文献

1
Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.长链非编码RNA MEG3的下调与宫颈癌的不良预后及启动子高甲基化相关。
J Exp Clin Cancer Res. 2017 Jan 5;36(1):5. doi: 10.1186/s13046-016-0472-2.
2
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications.用于生物标志物开发和临床应用的 DNA 甲基化分析方法的定量比较。
Nat Biotechnol. 2016 Jul;34(7):726-37. doi: 10.1038/nbt.3605. Epub 2016 Jun 27.
3
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
循环肿瘤DNA(ctDNA)在宫颈癌及其前驱病变中的临床应用与价值:从筛查到预测性生物标志物
Cancer Cell Int. 2023 Dec 18;23(1):329. doi: 10.1186/s12935-023-03132-0.
4
Silencing of the MEG3 gene promoted anti-cancer activity and drug sensitivity in glioma.沉默 MEG3 基因可增强脑胶质瘤的抗癌活性和药物敏感性。
J Cell Mol Med. 2023 Sep;27(17):2603-2613. doi: 10.1111/jcmm.17883. Epub 2023 Jul 31.
5
Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory.尿液、血液和口腔标本中人乳头瘤病毒检测:实验室最新进展。
J Clin Microbiol. 2023 Aug 23;61(8):e0140322. doi: 10.1128/jcm.01403-22. Epub 2023 Jul 13.
6
Loss of MEG3 contributes to the enhanced migration and invasion in arsenic-induced carcinogenesis through NQO1/FSCN1 pathway.MEG3的缺失通过NQO1/FSCN1途径促进了砷诱导致癌过程中迁移和侵袭能力的增强。
Am J Cancer Res. 2023 Jun 15;13(6):2307-2322. eCollection 2023.
7
Long non-coding RNAs as promising biomarkers and therapeutic targets in cervical cancer.长链非编码RNA作为宫颈癌中有前景的生物标志物和治疗靶点。
Noncoding RNA Res. 2023 Feb 21;8(2):233-239. doi: 10.1016/j.ncrna.2023.02.006. eCollection 2023 Jun.
8
A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers.lncRNA MEG3的当前证据综述:一种在多种癌症中发挥作用的肿瘤抑制因子
Front Cell Dev Biol. 2022 Dec 5;10:997633. doi: 10.3389/fcell.2022.997633. eCollection 2022.
9
Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients.宫颈癌患者中CADM1和MAL的联合液体活检甲基化分析
Cancers (Basel). 2022 Aug 16;14(16):3954. doi: 10.3390/cancers14163954.
10
LncRNA MEG3 inhibits retinoblastoma invasion and metastasis by inducing β-catenin degradation.长链非编码RNA MEG3通过诱导β-连环蛋白降解来抑制视网膜母细胞瘤的侵袭和转移。
Am J Cancer Res. 2022 Jul 15;12(7):3111-3127. eCollection 2022.
血浆DNA甲基化:非酒精性脂肪性肝病中肝纤维化分层的潜在生物标志物。
Gut. 2017 Jul;66(7):1321-1328. doi: 10.1136/gutjnl-2016-311526. Epub 2016 Mar 21.
4
Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.MEG3表达降低促进视网膜母细胞瘤进展,并通过调节Wnt/β-连环蛋白信号通路的活性影响视网膜母细胞瘤细胞生长。
Tumour Biol. 2016 Feb;37(2):1461-9. doi: 10.1007/s13277-015-4564-y. Epub 2015 Dec 10.
5
The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.腺苷介导长链非编码 RNA MEG3 激活的机制及其对人肝癌细胞的抗肿瘤作用。
Int J Oncol. 2016 Jan;48(1):421-9. doi: 10.3892/ijo.2015.3248. Epub 2015 Nov 18.
6
Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.长链非编码RNA MEG3在宫颈癌中表达下调,并通过调控miR-21影响细胞增殖和凋亡。
Cancer Biol Ther. 2016;17(1):104-13. doi: 10.1080/15384047.2015.1108496.
7
Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.血浆DNA中Zic1启动子高甲基化是胃癌和上皮内瘤变的潜在生物标志物。
PLoS One. 2015 Jul 24;10(7):e0133906. doi: 10.1371/journal.pone.0133906. eCollection 2015.
8
The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc.长链非编码RNA PCAT-1通过cMyc促进前列腺癌细胞增殖。
Neoplasia. 2014 Nov 20;16(11):900-8. doi: 10.1016/j.neo.2014.09.001. eCollection 2014 Nov.
9
Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer.新型长链非编码RNA RP11-462C24.1的低表达提示其可能作为结直肠癌预后不良的生物标志物。
Med Oncol. 2014 Jul;31(7):31. doi: 10.1007/s12032-014-0031-7. Epub 2014 Jun 8.
10
Refining insight into cervical cancer progression.
Lancet Oncol. 2014 Apr;15(4):371-2. doi: 10.1016/S1470-2045(14)70085-3. Epub 2014 Mar 19.